Related Experiment Video
Updated: Mar 9, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy
Wei-Bo Le1, Jing-Song Shi1, Tao Zhang2
1National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China; and.
Abstract:
Idiopathic membranous nephropathy (MN) is associated with HLA; however, the HLA allele involved remains unknown. To identify the HLA risk alleles associated with phospholipase A2 receptor (PLA2R)-related MN in the Chinese population, we sequenced the entire MHC region in DNA samples from 99 patients with PLA2R-related MN, 50 patients with PLA2R-unrelated MN, and 100 healthy subjects. Two HLA risk alleles, HLA-DRB1*15:01 and HLA-DRB3*02:02, independently and strongly associated with an increased risk of PLA2R-related MN. After adjusting for HLA-DRB1*15:01 and HLA-DRB3*02:02, no other alleles showed significant association with PLA2R-related MN. A replication study in an independent cohort of 293 participants with PLA2R-related MN and 285 healthy controls validated these findings. In a joint analysis, a multivariate logistic regression model confirmed that HLA-DRB1*15:01 (odds ratio [OR], 24.9; 95% confidence interval [95% CI], 15.3 to 42.6; P=2.3×10-35) and HLA-DRB3*02:02 (OR, 17.7; 95% CI, 11.0 to 30.3; P=8.0×10-29) independently and strongly associated with PLA2R-related MN. As many as 98.7% of patients with PLA2R-related MN, compared with 43.9% of control subjects, carried at least one HLA risk allele. Subjects with either risk allele had higher odds of developing PLA2R-related MN than those without a risk allele (OR, 98.9; 95% CI, 44.4 to 281.7; P=2.5×10-23). These HLA risk alleles also associated with the age at disease onset in patients with PLA2R-related MN. In conclusion, our findings provide clear evidence that the HLA-DRB1*15:01 and HLA-DRB3*02:02 alleles independently and strongly associate with PLA2R-related MN in the Chinese population.
Insights
Two specific HLA alleles, HLA-DRB1*15:01 and HLA-DRB3*02:02, significantly increase the risk of developing phospholipase A2 receptor-related membranous nephropathy (PLA2R-MN) in the Chinese population. These genetic factors are strongly associated with disease development and onset age.
Area of Science:
- Immunogenetics
- Nephrology
- Human Genetics
Background:
- Idiopathic membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
- The role of human leukocyte antigen (HLA) associations in phospholipase A2 receptor (PLA2R)-related MN is not fully understood.
- Identifying specific HLA alleles is crucial for understanding disease pathogenesis and risk stratification.
Purpose of the Study:
- To identify specific HLA risk alleles associated with PLA2R-related MN in the Chinese population.
- To validate the association of identified HLA alleles with PLA2R-MN risk.
- To investigate the impact of these HLA alleles on disease onset.
Main Methods:
- Whole MHC region sequencing in patients with PLA2R-related MN, PLA2R-unrelated MN, and healthy controls.
- Case-control association study with replication in an independent cohort.
- Multivariate logistic regression analysis to determine independent risk alleles and their odds ratios.
Main Results:
- HLA-DRB1*15:01 and HLA-DRB3*02:02 were identified as strong, independent risk alleles for PLA2R-related MN.
- Nearly all patients (98.7%) with PLA2R-MN carried at least one risk allele, compared to 43.9% of controls.
- These risk alleles were also associated with earlier age of disease onset.
Conclusions:
- HLA-DRB1*15:01 and HLA-DRB3*02:02 are significant independent risk factors for PLA2R-related MN in the Chinese population.
- These findings provide critical insights into the genetic susceptibility of PLA2R-MN.
- The identified HLA alleles may serve as potential biomarkers for disease risk and onset prediction.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018